Skip to content
PubMed This is a summary of 6 peer-reviewed journal articles Updated

Why Is an MRI Used to Diagnose IMNM? What It Shows

At a Glance

MRI does not diagnose immune-mediated necrotizing myopathy (IMNM) on its own. It maps muscle injury, shows active swelling and longer-term fatty replacement, and can help doctors select a moderately affected muscle for biopsy.

When diagnosing Immune-Mediated Necrotizing Myopathy (IMNM), doctors may order a Magnetic Resonance Imaging (MRI) scan. An MRI is a non-invasive imaging test that gives your care team a broad view of your muscle health in the scanned area [1]. It cannot confirm an IMNM diagnosis on its own, but doctors can use specific MRI settings to see which muscles show signs of active injury and which have sustained chronic changes [2]. This map of muscle involvement helps them better understand your condition and, when needed, helps identify a good location for a muscle biopsy [3].

Seeing the Big Picture

A muscle biopsy can be an important step for diagnosing IMNM, particularly if your blood tests do not show specific autoantibodies (immune proteins that mistakenly target your own tissues, such as anti-SRP or anti-HMGCR) [4]. However, not everyone needs a biopsy; if your symptoms, autoantibody tests, and other labs provide a clear picture, a biopsy may not be necessary.

When a biopsy is needed, it only looks at a tiny piece of one specific muscle. An MRI of your thigh or pelvis, however, can reveal the extent of involvement across the entire scanned area, sometimes catching muscle injury that hasn’t yet caused noticeable weakness [3].

Spotting Active Muscle Injury with STIR Sequences

To get the most useful information, doctors use different MRI settings. One important setting is the STIR sequence (Short Tau Inversion Recovery). STIR sequences are highly sensitive to fluids, causing areas with increased water content to light up on the scan [5].

In IMNM, this bright signal indicates edema (swelling or increased water in the muscle) [2]. While edema can be a sign of active muscle injury, it is not specific to IMNM. Edema can also occur from exercise, trauma, or other conditions. Because IMNM causes muscle cell death (necrosis) often with very little inflammation, edema here reflects injury rather than just inflammation [5]. Therefore, your doctor will interpret these MRI findings alongside your symptoms, physical exam, and blood tests (like creatine kinase, or CK) to understand if the disease is active [2].

Helping to Choose a Biopsy Site

If a biopsy is planned, an MRI can help guide the decision of where to test [1]. Over time, IMNM can cause chronic structural changes, replacing healthy muscle tissue with fat (a process called fatty replacement) [6].

If a doctor biopsies a muscle that has already undergone severe fatty replacement, the sample might be too damaged to provide clear diagnostic answers. Conversely, a muscle that isn’t actively involved might look completely normal under a microscope. By looking for muscles with active edema—but avoiding those with severe fatty replacement—your doctor can identify a moderately affected, viable muscle to sample [1][2]. While disease can be patchy and an MRI cannot guarantee a definitive diagnosis, it improves the chances of capturing useful tissue [1].

Understanding Chronic Changes

Beyond guiding a biopsy, an MRI helps your care team characterize the disease in the scanned area. While STIR sequences highlight active edema, another MRI setting called T1-weighted imaging shows the structure of fat and muscle, revealing where muscle atrophy (shrinkage) and fatty replacement have occurred [2]. Research shows that fatty replacement can begin early in the disease process [6]. By mapping both active injury and chronic, potentially lasting changes, your doctor can better assess the condition of your muscles [2].

While repeat MRIs are sometimes used to see how muscles look after treatment, they are not mandatory for everyone. Your doctor will primarily monitor your response to therapy by tracking your muscle strength, physical function, and blood tests (like CK levels) [2].

What to Expect During the MRI

An MRI is a safe procedure that does not use radiation. However, there are a few practical things to know:

  • It is loud and confined: You will lie inside a tube-like machine that makes loud knocking noises. You will be given earplugs or headphones.
  • You must remain still: Movement can blur the images.
  • Metal screening is required: Because the MRI uses powerful magnets, you must tell the imaging team about any metal in your body (like implanted devices, pacemakers, or joint replacements).
  • Tell your team if you have severe claustrophobia so they can help you feel more comfortable.

Common questions in this guide

Can an MRI confirm that I have IMNM?
No. An MRI can show which muscles are injured and whether changes look active or long-standing, but the findings are not specific to IMNM. Doctors combine the scan with your symptoms, examination, creatine kinase (CK) and autoantibody results, and sometimes a muscle biopsy.
What does a bright area on an IMNM MRI mean?
A bright area on a STIR image usually represents edema, or extra water in the muscle, which can signal active injury. Edema can also occur after exercise, trauma, or other conditions, so it does not prove IMNM by itself.
How can MRI help doctors choose a muscle biopsy site?
MRI maps more of the thigh or pelvic muscles than a biopsy can sample. Doctors may choose a muscle with active edema but avoid tissue with severe fatty replacement or a muscle that appears uninvolved, improving the chance that the sample will be useful.
What is the difference between STIR and T1 MRI images for IMNM?
STIR images are sensitive to extra water and can highlight active muscle injury. T1-weighted images show muscle structure, including atrophy and fatty replacement that can reflect longer-term damage.
What should I know before an MRI for IMNM?
MRI does not use radiation, but the machine is loud and enclosed, and you need to remain still. Tell the imaging team about implanted metal or devices and any severe claustrophobia; earplugs, headphones, or other accommodations may help.
Will I need repeat MRIs to monitor IMNM treatment?
Not necessarily. Some people have follow-up imaging, but clinicians commonly monitor treatment response with muscle strength, physical function, and CK blood levels. Your care team will decide whether another MRI is useful.

Get notified when new evidence is published on Immune-mediated necrotizing myopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    Immune Mediated Necrotizing Myopathy: a Cause of Isolated Myopathy of Neck Extensor Muscle.

    Sehgal R, Medina-Flores R, Yachoui R, Kenney CV

    Clinical medicine & research 2016; (14(3-4)):145-150 doi:10.3121/cmr.2016.1318.

    PMID: 27573534
  2. 2

    Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies.

    Fionda L, Lauletta A, Leonardi L, et al.

    Journal of neurology 2023; (270(2)):960-974 doi:10.1007/s00415-022-11447-7.

    PMID: 36329184
  3. 3

    The Characteristics of Imaging Patterns on Whole-body Magnetic Resonance Imaging of Anti-signal Recognition Particle Antibody-positive Immune-mediated Necrotizing Myopathy.

    Hou YY, Huang WC, Huang CR, et al.

    Acta neurologica Taiwanica 2025; (34(4)):216-223 doi:10.4103/ANT.ANT_113_0054.

    PMID: 41467261
  4. 4

    Peculiar clinicopathological features of immune-mediated necrotizing myopathies.

    Allenbach Y, Benveniste O

    Current opinion in rheumatology 2018; (30(6)):655-663 doi:10.1097/BOR.0000000000000547.

    PMID: 30239349
  5. 5

    Subclinical involvement of the trunk muscles in idiopathic inflammatory myopathies.

    Matsuda N, Kobayashi S, Hasegawa O, et al.

    Acta radiologica open 2022; (11(2)):20584601221075796 doi:10.1177/20584601221075796.

    PMID: 35251701
  6. 6

    Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI.

    Landon-Cardinal O, Koumako C, Hardouin G, et al.

    Seminars in arthritis and rheumatism 2020; (50(6)):1437-1440 doi:10.1016/j.semarthrit.2020.02.009.

    PMID: 32222382

This page explains how MRI may support an IMNM evaluation for informational purposes only and does not constitute medical advice. Ask your clinician how your scan, blood tests, and any biopsy decisions apply to you.